EFTA01862157.pdf

To: From: e rey Ps ern Sent: Thur 7/21/2011 11:10:46 AM Rothschild travels to Beijing to raise $750m private equity fund 21 Jul 2011 Source AltAssets Chairman of RIT Capital Partners Lord Rothschild travelled to Beijing this week to work on a private equity fund to raise renminbi in China and invest overseas. According to the Financial Times, the J. Rothschild Creat Partners fund hopes to raise $750m from Chinese investors by the end of the year. The vehicle is one of the first of its kind to gain regulatory approval by Chinese authorities, given the country's strict capital controls which make it difficult for companies and individuals to invest overseas. According to the report, capital markets in China have slowly been opening up to allow outbound investment, starting with equities and only recently allowing private equity funds. The fund, which is a venture between RIT Capital, Chinese investment group the Creat Group and investment advisory company Quercus Associates, is one of only two to have been approved so far. It will target sectors including clean energy, pharmaceuticals and natural resources, amongst others. "This unique venture will allow China's private sector to invest in Western companies, whilst providing opportunities for Western companies to enter China's rapidly growing and vibrant economy." said Rothschild when the fund was announced in March. *********************************************************** The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by c-mail to ices acation(f gmail.com, and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA_R1_00263072 EFTA01862157